The iodine market has seen considerable growth due to a variety of factors.
• The scale of the iodine market has expanded impressively in recent years. It is projected to increase from $2.71 billion in 2024 to $2.95 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.87%.
This growth during the historic period is associated with a rise in demand in the medical sector, heightened usage in water treatment, expanding applications in veterinary medicine, growing demand for biocides and disinfectants, as well as the fluctuating prices of crude iodine.
The iodine market is expected to maintain its strong growth trajectory in upcoming years.
• Predictions indicate a robust expansion of the iodine market in the upcoming years. The market worth is projected to reach $4.09 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.50%.
This growth during the forecast period is expected to be driven by factors such as the rising demand in the healthcare sector, increased use in water purification, expanding veterinary applications, increased demand for biocides and disinfectants, and varying crude iodine prices. Key trends during the forecast period comprise advanced membrane separation technologies, intelligent disinfection and antimicrobial items, nanotechnology and iodine nanoparticles, next-gen iodine-infused pharmaceuticals, and enhanced iodine-based LED and OLED technologies.
The increase in chronic diseases is anticipated to stimulate the iodine market's expansion. Chronic diseases, long-term health issues that generally last longer than three months and frequently progress slowly, can all benefit from iodine due to its vital role in medical imaging, pharmaceutical uses, and dietary supplements aimed at managing and preventing these illnesses. Chronic conditions like thyroid disorders, heart diseases, and cancer are increasingly demanding iodine. Iodine is paramount in managing these prolonged diseases by promoting thyroid function, overseeing metabolism, strengthening immune response, and alleviating inflammation, all of which enhance overall health and fortify resistance to diseases. For instance, projections from the National Library of Medicine, a medical library in the US, shows that by 2050, it is predicted that 142.66 million Americans over the age of 50 will be affected by at least one chronic disease. Hence, this surge in chronic diseases is propelling the iodine market's growth.
The iodine market covered in this report is segmented –
1) By Form: Inorganic Salts And Complexes, Elemental And Isotopes, Organic Compound
2) By Source: Underground Brines, Seaweeds, Caliche Ore, Recycling
3) By Application: Pharmaceuticals, Biocides, Iodophors, X-Ray Contrast Media, Catalyst In Polymer Processing, Optical Polarizing Films, Human Nutrition, Fluorochemicals, Animal Feed, Other Applications
Subsegments:
1) By Inorganic Salts And Complexes: Sodium Iodide, Potassium Iodide, Calcium Iodate
2) By Elemental And Isotopes: Elemental Iodine, Iodine-131, Iodine-123
3) By Organic Compound: Iodophors, Iodinated Contrast Media, Iodinated Organic Chemicals
Leading corporations in the iodine industry are emphasizing the creation of novel products like iodized salt. Their aim is to tackle the widespread iodine deficiency and bolster public health, especially in areas stricken with prevalence of deficiency-induced disorders. Iodized salt, which is table salt fortified with iodine, an essential trace mineral, is paramount in averting iodine deficiency that could result in thyroid-related health complications such as goiter, as well as developmental issues. To illustrate, Tata Consumer Products Limited, an Indian fast-moving consumer goods conglomerate, unveiled Shuddh by Tata Salt in February 2022. This premium iodized salt product aims to supply superior-quality salt with a higher purity level and intends to resolve iodine deficiency in Indian households by endorsing optimal health. This top-grade product is engineered to offer not just optimal purity, but also consistent and dependable iodine intake, responding to the escalating issue of iodine deficiency in the nation. The salt undergoes meticulous sourcing and refining, assuring it adheres to the stringent measures of quality and safety. Its launch underscores the brand's resolution to enhance public health by expanding iodine accessibility, ultimately fostering overall health enhancement, especially for households and individuals aiming to augment their everyday nutrition.
Major companies operating in the iodine market are include:
• Sociedad Química y Minera de Chile S.A.
• MilliporeSigma
• Albemarle Corporation
• ACF Minera S.A.
• BASF SE
• Nippoh Chemicals Co. Ltd.
• ISE Chemicals Corporation
• Algorta Norte S.A.
• Godo Shigen Co. Ltd.
• Iofina plc
• American Elements
• Chemlock Metals Corporation
• Iochem Corporation
• Deepwater Chemicals Inc.
• Kanto Chemical Co. Inc.
• Eskay Iodine
• Salvi Chemicals Industries Limited
• Azer Yod LLC
• SAGAR Life Sciences Private Limited
• Junsei Chemical Co. Ltd.
Europe was the largest region in the iodine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iodine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.